Zoetis Statement on Social Media Rumors
We are aware of the very vibrant communities of pet owners that share their stories and pictures of their pets online. Some of them even chose to share their success stories with us.
We also understand that when your pet becomes sick, it is natural to search for answers. While social media can be a valuable source for pet owners to gather information, anecdotes and advice, community experiences such as those provided by these social media groups and forums are not a substitute for accurate answers from veterinary experts.
If you have questions about medications for your pet and/or are concerned that your pet may be experiencing an adverse reaction to any medication, it is essential that you speak with your veterinarian. They know your pet and their medical history best, and an accurate diagnosis is essential to receiving the proper care.
Pet owners can also connect directly with our team of veterinarians and veterinary technicians who can help answer your questions. They can be contacted here: https://www.zoetisus.com/product-support/vmips/pet-owner-contact
IMPORTANT SAFETY INFORMATION: For use in dogs only. Women who are pregnant, trying to conceive or breastfeeding should take extreme care to avoid self-injection. Hypersensitivity reactions, including anaphylaxis, could potentially occur with self-injection. Librela should not be used in breeding, pregnant or lactating dogs. Librela should not be administered to dogs with known hypersensitivity to bedinvetmab. The most common adverse events reported in a clinical study were urinary tract infections, bacterial skin infections and dermatitis. See full Prescribing Information.
INDICATIONS: For the control of pain associated with osteoarthritis in dogs.
